ID   RNF41_HUMAN             Reviewed;         317 AA.
AC   Q9H4P4; A6NFW0; B2RBT8; O75598;
DT   21-FEB-2006, integrated into UniProtKB/Swiss-Prot.
DT   21-FEB-2006, sequence version 2.
DT   10-MAY-2017, entry version 125.
DE   RecName: Full=E3 ubiquitin-protein ligase NRDP1;
DE            EC=2.3.2.27;
DE   AltName: Full=RING finger protein 41;
DE   AltName: Full=RING-type E3 ubiquitin transferase NRDP1 {ECO:0000305};
GN   Name=RNF41; Synonyms=FLRF, NRDP1; ORFNames=SBBI03;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RA   Zhang W., Cao X., Wan T., Yuan Z., He L., Li N., Zhu X., Tao Q.;
RT   "Hypothetical protein SBBI03.";
RL   Submitted (JUL-1998) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16541075; DOI=10.1038/nature04569;
RA   Scherer S.E., Muzny D.M., Buhay C.J., Chen R., Cree A., Ding Y.,
RA   Dugan-Rocha S., Gill R., Gunaratne P., Harris R.A., Hawes A.C.,
RA   Hernandez J., Hodgson A.V., Hume J., Jackson A., Khan Z.M.,
RA   Kovar-Smith C., Lewis L.R., Lozado R.J., Metzker M.L.,
RA   Milosavljevic A., Miner G.R., Montgomery K.T., Morgan M.B.,
RA   Nazareth L.V., Scott G., Sodergren E., Song X.-Z., Steffen D.,
RA   Lovering R.C., Wheeler D.A., Worley K.C., Yuan Y., Zhang Z.,
RA   Adams C.Q., Ansari-Lari M.A., Ayele M., Brown M.J., Chen G., Chen Z.,
RA   Clerc-Blankenburg K.P., Davis C., Delgado O., Dinh H.H., Draper H.,
RA   Gonzalez-Garay M.L., Havlak P., Jackson L.R., Jacob L.S., Kelly S.H.,
RA   Li L., Li Z., Liu J., Liu W., Lu J., Maheshwari M., Nguyen B.-V.,
RA   Okwuonu G.O., Pasternak S., Perez L.M., Plopper F.J.H., Santibanez J.,
RA   Shen H., Tabor P.E., Verduzco D., Waldron L., Wang Q., Williams G.A.,
RA   Zhang J., Zhou J., Allen C.C., Amin A.G., Anyalebechi V., Bailey M.,
RA   Barbaria J.A., Bimage K.E., Bryant N.P., Burch P.E., Burkett C.E.,
RA   Burrell K.L., Calderon E., Cardenas V., Carter K., Casias K.,
RA   Cavazos I., Cavazos S.R., Ceasar H., Chacko J., Chan S.N., Chavez D.,
RA   Christopoulos C., Chu J., Cockrell R., Cox C.D., Dang M.,
RA   Dathorne S.R., David R., Davis C.M., Davy-Carroll L., Deshazo D.R.,
RA   Donlin J.E., D'Souza L., Eaves K.A., Egan A., Emery-Cohen A.J.,
RA   Escotto M., Flagg N., Forbes L.D., Gabisi A.M., Garza M., Hamilton C.,
RA   Henderson N., Hernandez O., Hines S., Hogues M.E., Huang M.,
RA   Idlebird D.G., Johnson R., Jolivet A., Jones S., Kagan R., King L.M.,
RA   Leal B., Lebow H., Lee S., LeVan J.M., Lewis L.C., London P.,
RA   Lorensuhewa L.M., Loulseged H., Lovett D.A., Lucier A., Lucier R.L.,
RA   Ma J., Madu R.C., Mapua P., Martindale A.D., Martinez E., Massey E.,
RA   Mawhiney S., Meador M.G., Mendez S., Mercado C., Mercado I.C.,
RA   Merritt C.E., Miner Z.L., Minja E., Mitchell T., Mohabbat F.,
RA   Mohabbat K., Montgomery B., Moore N., Morris S., Munidasa M.,
RA   Ngo R.N., Nguyen N.B., Nickerson E., Nwaokelemeh O.O., Nwokenkwo S.,
RA   Obregon M., Oguh M., Oragunye N., Oviedo R.J., Parish B.J.,
RA   Parker D.N., Parrish J., Parks K.L., Paul H.A., Payton B.A., Perez A.,
RA   Perrin W., Pickens A., Primus E.L., Pu L.-L., Puazo M., Quiles M.M.,
RA   Quiroz J.B., Rabata D., Reeves K., Ruiz S.J., Shao H., Sisson I.,
RA   Sonaike T., Sorelle R.P., Sutton A.E., Svatek A.F., Svetz L.A.,
RA   Tamerisa K.S., Taylor T.R., Teague B., Thomas N., Thorn R.D.,
RA   Trejos Z.Y., Trevino B.K., Ukegbu O.N., Urban J.B., Vasquez L.I.,
RA   Vera V.A., Villasana D.M., Wang L., Ward-Moore S., Warren J.T.,
RA   Wei X., White F., Williamson A.L., Wleczyk R., Wooden H.S.,
RA   Wooden S.H., Yen J., Yoon L., Yoon V., Zorrilla S.E., Nelson D.,
RA   Kucherlapati R., Weinstock G., Gibbs R.A.;
RT   "The finished DNA sequence of human chromosome 12.";
RL   Nature 440:346-351(2006).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Leiomyosarcoma, and Lymph;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 169-317 (ISOFORM 1).
RC   TISSUE=Lymphoblast;
RA   Zhou J., Yu W., Tang H., Mei G., Tsang Y.T.M., Bouck J., Gibbs R.A.,
RA   Margolin J.F.;
RL   Submitted (JUL-2000) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   FUNCTION, INTERACTION WITH ERBB3, MUTAGENESIS OF CYS-34; HIS-36 AND
RP   ASP-56, AND TISSUE SPECIFICITY.
RX   PubMed=12411582; DOI=10.1073/pnas.232580999;
RA   Qiu X.-B., Goldberg A.L.;
RT   "Nrdp1/FLRF is a ubiquitin ligase promoting ubiquitination and
RT   degradation of the epidermal growth factor receptor family member,
RT   ErbB3.";
RL   Proc. Natl. Acad. Sci. U.S.A. 99:14843-14848(2002).
RN   [8]
RP   FUNCTION, AND INTERACTION WITH BIRC6.
RX   PubMed=14765125; DOI=10.1038/sj.emboj.7600075;
RA   Qiu X.B., Markant S.L., Yuan J., Goldberg A.L.;
RT   "Nrdp1-mediated degradation of the gigantic IAP, BRUCE, is a novel
RT   pathway for triggering apoptosis.";
RL   EMBO J. 23:800-810(2004).
RN   [9]
RP   AUTOUBIQUITINATION, INTERACTION WITH USP8, DEUBIQUITINATION BY USP8,
RP   AND MUTAGENESIS OF CYS-34 AND HIS-36.
RX   PubMed=15314180; DOI=10.1128/MCB.24.17.7748-7757.2004;
RA   Wu X., Yen L., Irwin L., Sweeney C., Carraway K.L. III;
RT   "Stabilization of the E3 ubiquitin ligase Nrdp1 by the
RT   deubiquitinating enzyme USP8.";
RL   Mol. Cell. Biol. 24:7748-7757(2004).
RN   [10]
RP   FUNCTION, AND INTERACTION WITH PRKN.
RX   PubMed=15632191; DOI=10.1074/jbc.M408955200;
RA   Zhong L., Tan Y., Zhou A., Yu Q., Zhou J.;
RT   "RING finger ubiquitin-protein isopeptide ligase Nrdp1/FLRF regulates
RT   parkin stability and activity.";
RL   J. Biol. Chem. 280:9425-9430(2005).
RN   [11]
RP   FUNCTION, AND UBIQUITINATION.
RX   PubMed=17210635; DOI=10.1128/MCB.01245-06;
RA   Cao Z., Wu X., Yen L., Sweeney C., Carraway K.L. III;
RT   "Neuregulin-induced ErbB3 downregulation is mediated by a protein
RT   stability cascade involving the E3 ubiquitin ligase Nrdp1.";
RL   Mol. Cell. Biol. 27:2180-2188(2007).
RN   [12]
RP   FUNCTION, AND INTERACTION WITH PRKN.
RX   PubMed=18541373; DOI=10.1016/j.neulet.2008.05.052;
RA   Yu F., Zhou J.;
RT   "Parkin is ubiquitinated by Nrdp1 and abrogates Nrdp1-induced
RT   oxidative stress.";
RL   Neurosci. Lett. 440:4-8(2008).
RN   [13]
RP   FUNCTION, AND UBIQUITINATION OF MYD88 AND TBK1.
RX   PubMed=19483718; DOI=10.1038/ni.1742;
RA   Wang C., Chen T., Zhang J., Yang M., Li N., Xu X., Cao X.;
RT   "The E3 ubiquitin ligase Nrdp1 'preferentially' promotes TLR-mediated
RT   production of type I interferon.";
RL   Nat. Immunol. 10:744-752(2009).
RN   [14]
RP   FUNCTION IN MITOPHAGY.
RX   PubMed=24949970; DOI=10.1016/j.cell.2014.05.016;
RA   Soleimanpour S.A., Gupta A., Bakay M., Ferrari A.M., Groff D.N.,
RA   Fadista J., Spruce L.A., Kushner J.A., Groop L., Seeholzer S.H.,
RA   Kaufman B.A., Hakonarson H., Stoffers D.A.;
RT   "The diabetes susceptibility gene Clec16a regulates mitophagy.";
RL   Cell 157:1577-1590(2014).
RN   [15]
RP   X-RAY CRYSTALLOGRAPHY (1.87 ANGSTROMS) OF 193-317 IN COMPLEX WITH
RP   USP8.
RX   PubMed=17035239; DOI=10.1074/jbc.M606704200;
RA   Avvakumov G.V., Walker J.R., Xue S., Finerty P.J. Jr., Mackenzie F.,
RA   Newman E.M., Dhe-Paganon S.;
RT   "Amino-terminal dimerization, NRDP1-rhodanese interaction, and
RT   inhibited catalytic domain conformation of the ubiquitin-specific
RT   protease 8 (USP8).";
RL   J. Biol. Chem. 281:38061-38070(2006).
CC   -!- FUNCTION: Acts as E3 ubiquitin-protein ligase and regulates the
CC       degradation of target proteins. Polyubiquitinates MYD88.
CC       Negatively regulates MYD88-dependent production of proinflammatory
CC       cytokines. Can promote TRIF-dependent production of type I
CC       interferon and inhibits infection with vesicular stomatitis virus
CC       (By similarity). Promotes also activation of TBK1 and IRF3.
CC       Involved in the ubiquitination of erythropoietin (EPO) and
CC       interleukin-3 (IL-3) receptors. Thus, through maintaining basal
CC       levels of cytokine receptors, RNF41 is involved in the control of
CC       hematopoietic progenitor cell differentiation into myeloerythroid
CC       lineages (By similarity). Contributes to the maintenance of
CC       steady-state ERBB3 levels by mediating its growth factor-
CC       independent degradation. Involved in the degradation of the
CC       inhibitor of apoptosis BIRC6 and thus is an important regulator of
CC       cell death by promoting apoptosis. Acts also as a PRKN modifier
CC       that accelerates its degradation, resulting in a reduction of PRKN
CC       activity, influencing the balance of intracellular redox state.
CC       The RNF41-PRKN pathway regulates autophagosome-lysosome fusion
CC       during late mitophagy. Mitophagy is a selective form of autophagy
CC       necessary for mitochondrial quality control (PubMed:24949970).
CC       {ECO:0000250, ECO:0000250|UniProtKB:Q8BH75,
CC       ECO:0000269|PubMed:12411582, ECO:0000269|PubMed:14765125,
CC       ECO:0000269|PubMed:15632191, ECO:0000269|PubMed:17210635,
CC       ECO:0000269|PubMed:18541373, ECO:0000269|PubMed:19483718,
CC       ECO:0000269|PubMed:24949970}.
CC   -!- CATALYTIC ACTIVITY: S-ubiquitinyl-[E2 ubiquitin-conjugating
CC       enzyme]-L-cysteine + [acceptor protein]-L-lysine = [E2 ubiquitin-
CC       conjugating enzyme]-L-cysteine + N(6)-ubiquitinyl-[acceptor
CC       protein]-L-lysine.
CC   -!- PATHWAY: Protein modification; protein ubiquitination.
CC   -!- SUBUNIT: Interacts with USP8, ERBB3, PRKN and BIRC6. Interacts
CC       with CSF2RB, EPOR, IL3RA, MYD88 and TBK1. Interacts with CLEC16A
CC       (By similarity). {ECO:0000250}.
CC   -!- INTERACTION:
CC       Q66PJ3-3:ARL6IP4; NbExp=3; IntAct=EBI-2130266, EBI-10248982;
CC       Q9NWX5:ASB6; NbExp=5; IntAct=EBI-2130266, EBI-6425205;
CC       Q9NX04:C1orf109; NbExp=5; IntAct=EBI-2130266, EBI-8643161;
CC       Q9UHY7:ENOPH1; NbExp=4; IntAct=EBI-2130266, EBI-726969;
CC       Q9NSB8:HOMER2; NbExp=3; IntAct=EBI-2130266, EBI-2126733;
CC       Q86U28:ISCA2; NbExp=5; IntAct=EBI-2130266, EBI-10258659;
CC       Q9BRK4:LZTS2; NbExp=3; IntAct=EBI-2130266, EBI-741037;
CC       O15049:N4BP3; NbExp=3; IntAct=EBI-2130266, EBI-2512055;
CC       P35249:RFC4; NbExp=6; IntAct=EBI-2130266, EBI-476655;
CC       Q7LG56:RRM2B; NbExp=3; IntAct=EBI-2130266, EBI-9009083;
CC       Q9GZT4:SRR; NbExp=4; IntAct=EBI-2130266, EBI-9055653;
CC       Q99614:TTC1; NbExp=10; IntAct=EBI-2130266, EBI-742074;
CC       Q8N1B4:VPS52; NbExp=5; IntAct=EBI-2130266, EBI-2799833;
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q9H4P4-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9H4P4-2; Sequence=VSP_044670;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Detected in ovary, testis and prostate.
CC       {ECO:0000269|PubMed:12411582}.
CC   -!- PTM: Autoubiquitinated. Autoubiquitination leads to proteasomal
CC       degradation. Deubiquitinated by USP8 to get stabilized which
CC       induces apoptosis. {ECO:0000269|PubMed:15314180,
CC       ECO:0000269|PubMed:17210635, ECO:0000269|PubMed:19483718}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAG01988.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF077599; AAC27647.1; -; mRNA.
DR   EMBL; AK314811; BAG37335.1; -; mRNA.
DR   EMBL; AC073896; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471054; EAW96909.1; -; Genomic_DNA.
DR   EMBL; CH471054; EAW96910.1; -; Genomic_DNA.
DR   EMBL; BC024284; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; BC032637; AAH32637.1; -; mRNA.
DR   EMBL; AY007109; AAG01988.1; ALT_INIT; mRNA.
DR   CCDS; CCDS8909.1; -. [Q9H4P4-1]
DR   CCDS; CCDS8910.1; -. [Q9H4P4-2]
DR   RefSeq; NP_001229755.1; NM_001242826.1. [Q9H4P4-1]
DR   RefSeq; NP_005776.1; NM_005785.3. [Q9H4P4-1]
DR   RefSeq; NP_919339.1; NM_194358.2. [Q9H4P4-2]
DR   RefSeq; NP_919340.1; NM_194359.2. [Q9H4P4-1]
DR   RefSeq; XP_005268618.1; XM_005268561.4. [Q9H4P4-2]
DR   RefSeq; XP_011536036.1; XM_011537734.2. [Q9H4P4-2]
DR   RefSeq; XP_011536037.1; XM_011537735.2. [Q9H4P4-2]
DR   UniGene; Hs.524502; -.
DR   PDB; 2FZP; X-ray; 1.87 A; A=193-317.
DR   PDB; 2GWF; X-ray; 2.30 A; B/D/F=193-317.
DR   PDBsum; 2FZP; -.
DR   PDBsum; 2GWF; -.
DR   ProteinModelPortal; Q9H4P4; -.
DR   SMR; Q9H4P4; -.
DR   BioGrid; 115488; 70.
DR   IntAct; Q9H4P4; 52.
DR   STRING; 9606.ENSP00000342755; -.
DR   iPTMnet; Q9H4P4; -.
DR   PhosphoSitePlus; Q9H4P4; -.
DR   BioMuta; RNF41; -.
DR   DMDM; 88909120; -.
DR   EPD; Q9H4P4; -.
DR   MaxQB; Q9H4P4; -.
DR   PaxDb; Q9H4P4; -.
DR   PeptideAtlas; Q9H4P4; -.
DR   PRIDE; Q9H4P4; -.
DR   DNASU; 10193; -.
DR   Ensembl; ENST00000345093; ENSP00000342755; ENSG00000181852. [Q9H4P4-1]
DR   Ensembl; ENST00000394013; ENSP00000377581; ENSG00000181852. [Q9H4P4-2]
DR   Ensembl; ENST00000552656; ENSP00000447303; ENSG00000181852. [Q9H4P4-1]
DR   Ensembl; ENST00000615206; ENSP00000484671; ENSG00000181852. [Q9H4P4-1]
DR   GeneID; 10193; -.
DR   KEGG; hsa:10193; -.
DR   UCSC; uc001ske.3; human. [Q9H4P4-1]
DR   CTD; 10193; -.
DR   DisGeNET; 10193; -.
DR   GeneCards; RNF41; -.
DR   HGNC; HGNC:18401; RNF41.
DR   HPA; HPA016812; -.
DR   neXtProt; NX_Q9H4P4; -.
DR   OpenTargets; ENSG00000181852; -.
DR   PharmGKB; PA134875033; -.
DR   eggNOG; ENOG410ISDX; Eukaryota.
DR   eggNOG; ENOG410XNN7; LUCA.
DR   GeneTree; ENSGT00530000063647; -.
DR   HOGENOM; HOG000006561; -.
DR   HOVERGEN; HBG053154; -.
DR   InParanoid; Q9H4P4; -.
DR   KO; K11981; -.
DR   OMA; LMENCHE; -.
DR   OrthoDB; EOG091G0BKR; -.
DR   PhylomeDB; Q9H4P4; -.
DR   TreeFam; TF351947; -.
DR   BRENDA; 6.3.2.19; 2681.
DR   Reactome; R-HSA-1358803; Downregulation of ERBB2:ERBB3 signaling.
DR   Reactome; R-HSA-983168; Antigen processing: Ubiquitination & Proteasome degradation.
DR   UniPathway; UPA00143; -.
DR   EvolutionaryTrace; Q9H4P4; -.
DR   GeneWiki; RNF41; -.
DR   GenomeRNAi; 10193; -.
DR   PRO; PR:Q9H4P4; -.
DR   Proteomes; UP000005640; Chromosome 12.
DR   Bgee; ENSG00000181852; -.
DR   CleanEx; HS_RNF41; -.
DR   ExpressionAtlas; Q9H4P4; baseline and differential.
DR   Genevisible; Q9H4P4; HS.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0071782; C:endoplasmic reticulum tubular network; IDA:CAFA.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IDA:CAFA.
DR   GO; GO:0016881; F:acid-amino acid ligase activity; IEA:InterPro.
DR   GO; GO:0005128; F:erythropoietin receptor binding; IEA:Ensembl.
DR   GO; GO:0005135; F:interleukin-3 receptor binding; IEA:Ensembl.
DR   GO; GO:0019904; F:protein domain specific binding; IPI:CAFA.
DR   GO; GO:0031386; F:protein tag; IEA:InterPro.
DR   GO; GO:0017160; F:Ral GTPase binding; IPI:UniProtKB.
DR   GO; GO:0030971; F:receptor tyrosine kinase binding; IPI:CAFA.
DR   GO; GO:0061630; F:ubiquitin protein ligase activity; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0004842; F:ubiquitin-protein transferase activity; IDA:UniProtKB.
DR   GO; GO:0008270; F:zinc ion binding; IEA:InterPro.
DR   GO; GO:0006914; P:autophagy; IEA:UniProtKB-KW.
DR   GO; GO:0097191; P:extrinsic apoptotic signaling pathway; IDA:UniProtKB.
DR   GO; GO:0030336; P:negative regulation of cell migration; IMP:MGI.
DR   GO; GO:0008285; P:negative regulation of cell proliferation; IDA:MGI.
DR   GO; GO:1901525; P:negative regulation of macromitophagy; IEA:Ensembl.
DR   GO; GO:0045732; P:positive regulation of protein catabolic process; IMP:CAFA.
DR   GO; GO:2000379; P:positive regulation of reactive oxygen species metabolic process; IMP:ParkinsonsUK-UCL.
DR   GO; GO:0051091; P:positive regulation of sequence-specific DNA binding transcription factor activity; IEA:Ensembl.
DR   GO; GO:0010498; P:proteasomal protein catabolic process; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0051865; P:protein autoubiquitination; IDA:FlyBase.
DR   GO; GO:0000209; P:protein polyubiquitination; IDA:UniProtKB.
DR   GO; GO:2000114; P:regulation of establishment of cell polarity; IEA:Ensembl.
DR   GO; GO:0045619; P:regulation of lymphocyte differentiation; IEA:Ensembl.
DR   GO; GO:0043408; P:regulation of MAPK cascade; IDA:MGI.
DR   GO; GO:0045637; P:regulation of myeloid cell differentiation; IEA:Ensembl.
DR   GO; GO:0051896; P:regulation of protein kinase B signaling; IDA:MGI.
DR   GO; GO:2000377; P:regulation of reactive oxygen species metabolic process; IMP:UniProtKB.
DR   CDD; cd00162; RING; 1.
DR   Gene3D; 3.30.40.10; -; 2.
DR   InterPro; IPR008974; TRAF-like.
DR   InterPro; IPR015036; USP8_interacting.
DR   InterPro; IPR001841; Znf_RING.
DR   InterPro; IPR013083; Znf_RING/FYVE/PHD.
DR   InterPro; IPR017907; Znf_RING_CS.
DR   InterPro; IPR013010; Znf_SIAH.
DR   Pfam; PF08941; USP8_interact; 1.
DR   SMART; SM00184; RING; 1.
DR   SUPFAM; SSF49599; SSF49599; 1.
DR   PROSITE; PS00518; ZF_RING_1; 1.
DR   PROSITE; PS50089; ZF_RING_2; 1.
DR   PROSITE; PS51081; ZF_SIAH; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Apoptosis; Autophagy;
KW   Complete proteome; Metal-binding; Reference proteome; Transferase;
KW   Ubl conjugation; Ubl conjugation pathway; Zinc; Zinc-finger.
FT   CHAIN         1    317       E3 ubiquitin-protein ligase NRDP1.
FT                                /FTId=PRO_0000223954.
FT   ZN_FING      18     57       RING-type; degenerate.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00175}.
FT   ZN_FING      78    138       SIAH-type; degenerate.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00455}.
FT   VAR_SEQ       1     71       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_044670.
FT   MUTAGEN      34     34       C->S: Loss of activity; when associated
FT                                with Q-36. {ECO:0000269|PubMed:12411582,
FT                                ECO:0000269|PubMed:15314180}.
FT   MUTAGEN      36     36       H->Q: Loss of activity; when associated
FT                                with S-34. {ECO:0000269|PubMed:12411582,
FT                                ECO:0000269|PubMed:15314180}.
FT   MUTAGEN      56     56       D->V: Loss of activity.
FT                                {ECO:0000269|PubMed:12411582}.
FT   HELIX       193    205       {ECO:0000244|PDB:2FZP}.
FT   STRAND      206    211       {ECO:0000244|PDB:2FZP}.
FT   HELIX       214    216       {ECO:0000244|PDB:2FZP}.
FT   STRAND      217    220       {ECO:0000244|PDB:2FZP}.
FT   HELIX       223    235       {ECO:0000244|PDB:2FZP}.
FT   HELIX       240    248       {ECO:0000244|PDB:2FZP}.
FT   HELIX       252    254       {ECO:0000244|PDB:2FZP}.
FT   TURN        257    259       {ECO:0000244|PDB:2FZP}.
FT   HELIX       262    267       {ECO:0000244|PDB:2FZP}.
FT   TURN        268    270       {ECO:0000244|PDB:2FZP}.
FT   HELIX       271    274       {ECO:0000244|PDB:2FZP}.
FT   STRAND      277    279       {ECO:0000244|PDB:2FZP}.
FT   STRAND      283    289       {ECO:0000244|PDB:2FZP}.
FT   HELIX       290    292       {ECO:0000244|PDB:2FZP}.
FT   TURN        298    300       {ECO:0000244|PDB:2FZP}.
FT   STRAND      303    312       {ECO:0000244|PDB:2FZP}.
FT   STRAND      314    316       {ECO:0000244|PDB:2FZP}.
SQ   SEQUENCE   317 AA;  35905 MW;  46AE87AF8BE1A369 CRC64;
     MGYDVTRFQG DVDEDLICPI CSGVLEEPVQ APHCEHAFCN ACITQWFSQQ QTCPVDRSVV
     TVAHLRPVPR IMRNMLSKLQ IACDNAVFGC SAVVRLDNLM SHLSDCEHNP KRPVTCEQGC
     GLEMPKDELP NHNCIKHLRS VVQQQQTRIA ELEKTSAEHK HQLAEQKRDI QLLKAYMRAI
     RSVNPNLQNL EETIEYNEIL EWVNSLQPAR VTRWGGMIST PDAVLQAVIK RSLVESGCPA
     SIVNELIENA HERSWPQGLA TLETRQMNRR YYENYVAKRI PGKQAVVVMA CENQHMGDDM
     VQEPGLVMIF AHGVEEI
//
